Code intelligence

C65.9 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code C65.9.

Critical code riskView ICD-10 detail

Signal breakdown

3 shown · 3 total in platform

Risk: Critical

Critical

67%

High

33%

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

Proposed LCD DL40435: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Noridian

Policy LCD-DL40435 · Oncology

Critical

Proposed LCD: Renal CA transcriptional biomarkers—comment by 10/11/26

View alert

Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Palmetto GBA

Policy LCD-DL40429 · Oncology

Critical

Proposed LCD: Molecular biomarkers for renal carcinoma tx decisions—comment by 1

View alert

Proposed LCD DL40433: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — CGS

Policy LCD-DL40433 · Oncology

High

Proposed LCD: Renal carcinoma transcriptional biomarkers—comment by 10/11/26

View alert

Audit documentation

Building an audit file that includes C65.9?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription